EVOFEM BIOSCIENCES INC's ticker is EVFM and the CUSIP is 30048L104. A total of 89 filers reported holding EVOFEM BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | – | 18,500 | +3600.0% | 0.00% | – |
| Q4 2021 | $0 | – | 500 | -3.8% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 520 | -97.0% | 0.00% | – |
| Q2 2021 | $19,000 | +11.8% | 17,130 | +82.6% | 0.00% | – |
| Q1 2021 | $17,000 | -43.3% | 9,379 | -23.8% | 0.00% | – |
| Q4 2020 | $30,000 | +57.9% | 12,312 | +53.5% | 0.00% | – |
| Q3 2020 | $19,000 | -20.8% | 8,021 | -6.9% | 0.00% | – |
| Q2 2020 | $24,000 | +200.0% | 8,616 | +487.3% | 0.00% | – |
| Q1 2020 | $8,000 | -11.1% | 1,467 | -1.3% | 0.00% | – |
| Q4 2019 | $9,000 | +200.0% | 1,487 | +181.6% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 528 | +5.6% | 0.00% | – |
| Q2 2019 | $3,000 | -25.0% | 500 | -50.4% | 0.00% | – |
| Q1 2019 | $4,000 | 0.0% | 1,008 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | 0.0% | 1,008 | +0.8% | 0.00% | – |
| Q3 2018 | $4,000 | +33.3% | 1,000 | -0.1% | 0.00% | – |
| Q2 2018 | $3,000 | +50.0% | 1,001 | +266.7% | 0.00% | – |
| Q1 2018 | $2,000 | – | 273 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Taylor Wealth Management Partners | 545,413 | $954,000 | 0.35% |
| HEARTLAND ADVISORS INC | 2,655,400 | $4,647,000 | 0.29% |
| Maven Securities LTD | 2,750,000 | $4,826,000 | 0.22% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 150,000 | $263,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 265,286 | $464,000 | 0.08% |
| GREAT LAKES ADVISORS, LLC | 1,697,052 | $2,970,000 | 0.05% |
| CAAS CAPITAL MANAGEMENT LP | 2,335,305 | $4,087,000 | 0.04% |
| Virtu Financial LLC | 174,447 | $305,000 | 0.02% |
| Game Plan Financial Advisors, LLC | 18,500 | $33,000 | 0.02% |
| Baker Brothers Advisors | 2,697,110 | $4,720,000 | 0.02% |